Φορτώνει......
Cancer Immunotherapy Using Checkpoint Blockade
The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses in patients with a variety of cancers. This can be achieved by antibodies blocking the cytotoxic T lymphocyte antigen-4 (CTL...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Science |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7391259/ https://ncbi.nlm.nih.gov/pubmed/29567705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aar4060 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|